Purchase Order 75N94020P00555
Award Date 8/20/20
Potential Completion Date 11/18/20
Potential Value $1.2M
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Billerica, MA 01821, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $587,061 firm fixed price purchase order to Bruker Biospin Corp. to acquire an Avance Neo 700 MHz NMR console compatible with an existing 700 MHz spectrometer located at NIH's campus in Bethesda, Maryland. The solicitation sought quotes for the NMR equipment upgrade by September 5, 2023, with delivery and installation within six to nine months of award. Evaluation factors included...
- The U.S. Department of Health and Human Services, National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $2,855,935.00 firm-fixed-price contract to Bruker Biospin Corp, a for-profit manufacturer, to provide five Avance Neo consoles for Bruker NMR spectrometers, a Q-band pulse 300 W amplifier for a Q-band pulsed EPR spectrometer, and two cryoplatforms for Bruker NMR spectrometers. This award supports upgrading the NMR and EPR...
- The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $232,162.20 firm fixed price purchase order to Bruker Biospin Corp. to acquire a CryoPlatformTM Annual Maintenance Agreement. The agreement will provide maintenance and repair services for NMR systems, valued at approximately $15 million, used by NIDDK to conduct research gaining a fundamental understanding of protein structure and protein-protein as well as protein-drug interactions...
- The Department of Health and Human Services' National Institute of Diabetes and Digestive and Kidney Diseases awarded a $15,514 firm fixed-price purchase order to Bruker Biospin Corp. for an AQS REFERENCE BOARD/3 1200. Bruker Biospin Corp. is a subsidiary of Bruker Corporation located in Billerica, Massachusetts. The order is to be completed by September 30, 2023 in support of NIDDK programs. No set-aside designation or subcontractors were identified. The award provides the research equipment...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, awarded a firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Corporation, to acquire a service contract for a CryoPlatform system. The $216,845.10 contract will be performed in Billerica, Massachusetts and has an ultimate completion date of September 27, 2023. The contract was awarded on September 28, 2022, and did not utilize any set-aside designations. The original...
- This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Bruker Biospin Corp, a subsidiary of the Bruker Corporation. The $322,000.00 firm fixed-price purchase order is for the delivery of scientific instrumentation, primarily nuclear magnetic resonance (NMR) spectrometers, magnetic resonance imaging (MRI) systems, and electron spin resonance (EPR) spectrometers. This award was not set aside and was competed...
- This is a $216,140.00 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Bruker Biospin Corp, a wholly-owned subsidiary of Bruker Corporation. The contract is for the delivery of a MARIUS CLORE IN 5/B1-301ER 4118HVCF5L FLEXLINE CRYOGEN-FREE VTSYSTEM, which is a specialized nuclear magnetic resonance (NMR) spectrometer system. The award does not utilize any set-aside designations. Bruker Biospin Corp is an established...
- This federal contract award, valued at $440,500.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Bruker Biospin Corp, a manufacturer of scientific instruments. The award is for the purchase of an AVANCE III HD 600 console, as described in the associated quote. The end user is Gideon Clore, and the contract does not have a set-aside designation. Bruker Biospin Corp is known to provide nuclear magnetic resonance spectrometers, upgrades, maintenance,...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded a $216,684 firm-fixed price purchase order to Bruker Biospin Corp. for a CryoPlatformTM Maintenance Agreement. This agreement will provide critical maintenance services for the agency's Nuclear Magnetic Resonance (NMR) spectrometers used in protein research. Bruker Biospin Corp. is the sole source provider of the proprietary CryoPlatform equipment and authorized maintenance services. This purchase order does...
- This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the U.S. Department of Health and Human Services, to Bruker Biospin Corp, a subsidiary of the Bruker Corporation. The $203,775.00 firm-fixed-price purchase order was awarded on September 10, 2016 with a completion date of September 18, 2017. Bruker Biospin Corp is a manufacturer of scientific instruments and provides specialized equipment, maintenance,...